Tumor Biology

, Volume 35, Issue 9, pp 9263–9268 | Cite as

ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells

  • Lin Fu
  • Nan Liu
  • Yong Han
  • Chengyao Xie
  • Qingchang Li
  • Enhua Wang
Research Article


A disintegrin and metalloprotease 10 (ADAM10) is upregulated in several cancers and associates with malignant cancer progression. However, its expression pattern in bladder cancer remains unexplored. In the present study, we examined ADAM10 expression in 105 bladder cancer specimens using immunohistochemistry. We found ADAM10 overexpression in 51 of 105 (48.5 %) bladder cancer specimens. ADAM10 overexpression associated with advanced tumor stage (p = 0.001) and tumor grade (p = 0.018). To explore its biological functions in bladder cancer cells, small interfering RNA (siRNA) knockdown was performed in 5,637 and T24 cell lines. Cell Counting Kit-8 (CCK8) assay and Matrigel invasion assay showed that ADAM10 depletion decreased cell proliferation, migration, and invasion. In addition, ADAM10 knockdown increased the level of cisplatin-induced apoptosis. In conclusion, ADAM10 is overexpressed in bladder cancer and regulates malignant cell growth and invasion, which makes it a candidate therapeutic target.


Bladder cancer Proliferation Invasion Migration Chemoresistance 


Conflicts of interest



  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62(1):10–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Han B, Luan L, Xu Z, Wu B. Expression and biological roles of SATB1 in human bladder cancer. Tumour Biol. 2013;34(5):2943–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Wang C, Wang W, Wang J, Zhan H, Jiang L, Yan R, et al. Apoptin induces apoptosis in nude mice allograft model of human bladder cancer by altering multiple bladder tumor-associated gene expression profiles. Tumour Biol. 2013;34(3):1667–78.CrossRefPubMedGoogle Scholar
  4. 4.
    Yan L, Yan K, Kun W, Xu L, Ma Q, Tang Y, et al. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase. Tumour Biol. 2013;34(1):215–21.CrossRefPubMedGoogle Scholar
  5. 5.
    Sanchez-Carbayo M. Hypermethylation in bladder cancer: biological pathways and translational applications. Tumour Biol. 2012;33(2):347–61.CrossRefPubMedGoogle Scholar
  6. 6.
    Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med. 2008;29(5):258–89.CrossRefPubMedGoogle Scholar
  7. 7.
    Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, et al. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie. 2008;90(2):369–79.CrossRefPubMedGoogle Scholar
  8. 8.
    Duffy MJ, McKiernan E, O’Donovan N, McGowan PM. Role of ADAMs in cancer formation and progression. Clin Cancer Res. 2009;15(4):1140–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Saftig P, Reiss K. The “A disintegrin and metalloproteasesˮ ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur J Cell Biol. 2011;90(6–7):527–35.CrossRefPubMedGoogle Scholar
  10. 10.
    Gaida MM, Haag N, Gunther F, Tschaharganeh DF, Schirmacher P, Friess H, et al. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma. Int J Mol Med. 2010;26(2):281–8.PubMedGoogle Scholar
  11. 11.
    Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW, Liu TY. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett. 2007;245(1–2):33–43.CrossRefPubMedGoogle Scholar
  12. 12.
    Lee SB, Schramme A, Doberstein K, Dummer R, Abdel-Bakky MS, Keller S, et al. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J Invest Dermatol. 2010;130(3):763–73.CrossRefPubMedGoogle Scholar
  13. 13.
    Guo J, He L, Yuan P, Wang P, Lu Y, Tong F, et al. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway. Oncol Rep. 2012;28(5):1709–18.PubMedGoogle Scholar
  14. 14.
    Lendeckel U, Kohl J, Arndt M, Carl-McGrath S, Donat H, Rocken C. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines. J Cancer Res Clin Oncol. 2005;131(1):41–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Yang CL, Jiang FQ, Xu F, Jiang GX. ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma. Tumour Biol. 2012;33(5):1535–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005;168(4):633–42.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Xu Q, Liu X, Chen W, Zhang Z. Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference. J Transl Med. 2010;8:136.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    D’Amelio M, Cavallucci V, and Cecconi F, Neuronal caspase-3 signaling: not only cell death. Cell Death Differ. 17(7): p. 1104-14.Google Scholar
  19. 19.
    Yan F, Liu Y, Wang W. Matrine inhibited the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis in a mitochondrial-caspase-dependent pathway. Tumour Biol. 2013;34(4):2135–40.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Lin Fu
    • 1
  • Nan Liu
    • 1
  • Yong Han
    • 1
  • Chengyao Xie
    • 1
  • Qingchang Li
    • 1
  • Enhua Wang
    • 1
  1. 1.Department of Pathology, College of Basic Medical SciencesThe First Affiliated Hospital and China Medical UniversityShenyangChina

Personalised recommendations